These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 20041225)

  • 1. Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.
    Gao X; Wan F; Mateo K; Callegari E; Wang D; Deng W; Puente J; Li F; Chaussee MS; Finlay BB; Lenardo MJ; Hardwidge PR
    PLoS Pathog; 2009 Dec; 5(12):e1000708. PubMed ID: 20041225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2.
    Pham TH; Gao X; Tsai K; Olsen R; Wan F; Hardwidge PR
    Infect Immun; 2012 Jun; 80(6):2133-40. PubMed ID: 22451523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli virulence protein NleH1 interaction with the v-Crk sarcoma virus CT10 oncogene-like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/nuclear factor κB (NF-κB) pathway.
    Pham TH; Gao X; Singh G; Hardwidge PR
    J Biol Chem; 2013 Nov; 288(48):34567-74. PubMed ID: 24145029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7.
    Wan F; Weaver A; Gao X; Bern M; Hardwidge PR; Lenardo MJ
    Nat Immunol; 2011 Apr; 12(4):335-43. PubMed ID: 21399639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.
    Royan SV; Jones RM; Koutsouris A; Roxas JL; Falzari K; Weflen AW; Kim A; Bellmeyer A; Turner JR; Neish AS; Rhee KJ; Viswanathan VK; Hecht GA
    Mol Microbiol; 2010 Dec; 78(5):1232-45. PubMed ID: 21091507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction.
    Hodgson A; Wier EM; Fu K; Sun X; Yu H; Zheng W; Sham HP; Johnson K; Bailey S; Vallance BA; Wan F
    PLoS Pathog; 2015 Mar; 11(3):e1004705. PubMed ID: 25756944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and regulation of the Escherichia coli O157:H7 effector proteins NleH1 and NleH2.
    Holmes A; Lindestam Arlehamn CS; Wang D; Mitchell TJ; Evans TJ; Roe AJ
    PLoS One; 2012; 7(3):e33408. PubMed ID: 22428045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90 Interacts with the Bacterial Effector NleH1.
    Wu M; Hardwidge PR
    Pathogens; 2018 Nov; 7(4):. PubMed ID: 30428538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPEC NleH1 is significantly more effective in reversing colitis and reducing mortality than NleH2 via differential effects on host signaling pathways.
    Kralicek SE; Nguyen M; Rhee KJ; Tapia R; Hecht G
    Lab Invest; 2018 Apr; 98(4):477-488. PubMed ID: 29396422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SseL Deubiquitinates RPS3 to Inhibit Its Nuclear Translocation.
    Wu M; El Qaidi S; Hardwidge PR
    Pathogens; 2018 Nov; 7(4):. PubMed ID: 30405005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
    Newton HJ; Pearson JS; Badea L; Kelly M; Lucas M; Holloway G; Wagstaff KM; Dunstone MA; Sloan J; Whisstock JC; Kaper JB; Robins-Browne RM; Jans DA; Frankel G; Phillips AD; Coulson BS; Hartland EL
    PLoS Pathog; 2010 May; 6(5):e1000898. PubMed ID: 20485572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of microvillus protein Eps8 by the NleH effector kinases from enteropathogenic
    Pollock GL; Grishin AM; Giogha C; Gan J; Oates CV; McMillan PJ; Gaeta I; Tyska MJ; Pearson JS; Scott NE; Cygler M; Hartland EL
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2204332119. PubMed ID: 35976880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.
    Sham HP; Shames SR; Croxen MA; Ma C; Chan JM; Khan MA; Wickham ME; Deng W; Finlay BB; Vallance BA
    Infect Immun; 2011 Sep; 79(9):3552-62. PubMed ID: 21746856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue.
    Nobe R; Nougayrède JP; Taieb F; Bardiau M; Cassart D; Navarro-Garcia F; Mainil J; Hayashi T; Oswald E
    Microbiology (Reading); 2009 Oct; 155(Pt 10):3214-3225. PubMed ID: 19628559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an N-terminal truncation of the NF-κB p65 subunit that specifically modulates ribosomal protein S3-dependent NF-κB gene expression.
    Wier EM; Neighoff J; Sun X; Fu K; Wan F
    J Biol Chem; 2012 Dec; 287(51):43019-29. PubMed ID: 23115242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut.
    Hemrajani C; Marches O; Wiles S; Girard F; Dennis A; Dziva F; Best A; Phillips AD; Berger CN; Mousnier A; Crepin VF; Kruidenier L; Woodward MJ; Stevens MP; La Ragione RM; MacDonald TT; Frankel G
    Infect Immun; 2008 Nov; 76(11):4804-13. PubMed ID: 18725419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA.
    Yen H; Ooka T; Iguchi A; Hayashi T; Sugimoto N; Tobe T
    PLoS Pathog; 2010 Dec; 6(12):e1001231. PubMed ID: 21187904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.
    Arbeloa A; Oates CV; Marchès O; Hartland EL; Frankel G
    Infect Immun; 2011 Mar; 79(3):1067-76. PubMed ID: 21189318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterohaemorrhagic, but not enteropathogenic, Escherichia coli infection of epithelial cells disrupts signalling responses to tumour necrosis factor-alpha.
    Gareau MG; Ho NK; Brenner D; Sousa AJ; LeBourhis L; Mak TW; Girardin SE; Philpott DJ; Sherman PM
    Microbiology (Reading); 2011 Oct; 157(Pt 10):2963-2973. PubMed ID: 21798984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.